The program consists of three scientific sessions covering virus and bacterial, parasitic research; vaccine development and therapeutic development. Distinguished experts from leading institutions in Australia, Canada, the United States, Cambodia, and Korea, representing academia, industry, and research institutes, will share the latest research outcomes and insights. These will include infectious disease responses such as seasonal and pandemic influenza and malaria, next-generation antibiotic design, advanced vaccine manufacturing platforms, AI-based vaccine development, and next-generation RNA delivery technologies.